Youzhi Zhu
Overview
Explore the profile of Youzhi Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Luo X, Zhu Y, Zhang Q, Liu B
Heliyon
. 2024 Jul;
10(12):e32619.
PMID: 38952379
Purpose: It is difficult to differentiate between primary central nervous system lymphoma and primary glioblastoma due to their similar MRI findings. This study aimed to assess whether pharmacokinetic parameters derived...
2.
Xie R, Lin J, Li W, Chen H, Zhang J, Zhong M, et al.
Life Sci
. 2024 May;
347:122682.
PMID: 38702025
Thyroid cancer is one of the most common primary endocrine malignancies worldwide, and papillary thyroid carcinoma (PTC) is the predominant histological type observed therein. Although PTC has been studied extensively,...
3.
Chen L, Zheng S, Chen L, Xu S, Wu K, Kong L, et al.
J Nucl Med
. 2023 Nov;
64(12):1899-1905.
PMID: 37918866
Ga-labeled fibroblast activation protein inhibitor (Ga-FAPI) PET/CT has demonstrated promising clinical results, with a higher SUV and tumor-to-background ratio (TBR) in breast cancer (BC) patients than F-FDG PET/CT. Here, we...
4.
Jiang C, Zhu Y, Chen H, Lin J, Xie R, Li W, et al.
Cell Death Dis
. 2023 Oct;
14(10):653.
PMID: 37803002
Tamoxifen-based endocrine therapy remains a major adjuvant therapy for estrogen receptor (ER)-positive breast cancer (BC). However, many patients develop tamoxifen resistance, which results in recurrence and poor prognosis. Herein, we...
5.
Cui W, Zhang J, Lin J, Xu S, Kong L, Lin W, et al.
J Biosci
. 2023 Aug;
48.
PMID: 37539552
N-methyladenosine modification and lncRNAs are closely related to the prognosis and immunotherapy response of breast cancer patients. LncRNAs related to m A-associated genes were predicted based on coexpression analysis of...
6.
Wang T, Zhu Y, Weng S, Lin X, Kong K, Weng Y, et al.
Biomed Opt Express
. 2023 Feb;
13(11):5962-5970.
PMID: 36733726
Monitoring the levels of cancer biomarkers is essential for cancer diagnosis and evaluation. In this study, a novel sandwich type sensing platform based on surface-enhanced Raman scattering (SERS) technology was...
7.
Zheng S, Lin J, Zhu Y, Chen Y, Zhang J, Chen X, et al.
Clin Nucl Med
. 2023 Feb;
48(3):e104-e109.
PMID: 36723892
Purpose: This study aimed to compare the performance of 68Ga-FAPI and 18F-FDG PET/CT in the evaluation of patients with newly diagnosed breast cancer. Methods: Thirty-four women with newly diagnosed breast...
8.
Zhu Y, Zhang J, Yu L, Xu S, Chen L, Wu K, et al.
Front Oncol
. 2023 Jan;
12:972969.
PMID: 36698419
Background: The clinical outcome of triple-negative breast cancer (TNBC) is poor. Finding more targets for the treatment of TNBC is an urgent need. SENPs are SUMO-specific proteins that play an...
9.
Ye Y, Lin Y, Chi Z, Zhang J, Cai F, Zhu Y, et al.
PeerJ
. 2022 Oct;
10:e14257.
PMID: 36312756
Herein, a versatile fluorescent bioanalysis platform for sensitive and specific screening of target miRNA (miR-129-2-3p) was innovatively designed by applying target-induced rolling circle amplification (RCA) for efficient signal amplification. Specifically,...
10.
Zhang Z, Fang Q, Zhang Y, Zhu Y, Zhang W, Zhu Y, et al.
Front Cardiovasc Med
. 2022 Oct;
9:1013610.
PMID: 36211577
Objective: Arterial spasm is proved to be an inducer of cerebral ischemia and cerebral infarction, while when a venous spasm occurs, cerebral edema is seen to be caused by a...